Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
66.38
+0.15 (0.23%)
Sep 5, 2025, 10:53 AM - Market open
Merus Market Cap
Merus has a market cap or net worth of $5.02 billion as of September 5, 2025. Its market cap has increased by 37.12% in one year.
Market Cap
5.02B
Enterprise Value
4.13B
1-Year Change
37.12%
Ranking
Category
Stock Price
$66.38
Market Cap Chart
Since May 19, 2016, Merus's market cap has increased from $143.00M to $5.02B, an increase of 3,410.92%. That is a compound annual growth rate of 46.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 5.01B | 74.00% |
| Dec 31, 2024 | 2.88B | 81.33% |
| Dec 29, 2023 | 1.59B | 121.65% |
| Dec 30, 2022 | 716.30M | -41.96% |
| Dec 31, 2021 | 1.23B | 142.03% |
| Dec 31, 2020 | 509.90M | 55.03% |
| Dec 31, 2019 | 328.90M | 20.92% |
| Dec 31, 2018 | 272.00M | -12.85% |
| Dec 29, 2017 | 312.10M | 3.83% |
| Dec 30, 2016 | 300.60M | 110.21% |
| May 19, 2016 | 143.00M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |